SureTrader
Home > Boards > US Listed > Biotechs > Rosetta Genomics Ltd (ROSG)

RSI still at 66.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Penny Gold Mine Member Profile
Member Level 
Followed By 207
Posts 6,616
Boards Moderated 1
Alias Born 12/14/09
160x600 placeholder
Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of Diagnostic Tests and Services "Business Wire" - 2/1/2016 8:00:00 AM
Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for Classification of Kidney Tumors "Business Wire" - 1/25/2016 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/19/2016 4:08:02 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/14/2016 2:48:03 PM
CORRECTING & REPLACING Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules for the Treatment of Liver... "Business Wire" - 1/11/2016 10:19:00 AM
Rosetta Genomics Granted U.S. Patent Allowance for Use of microRNA Molecules for the Treatment of Liver Cancer "Business Wire" - 1/11/2016 9:11:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 1/6/2016 4:51:32 PM
Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the Development of Oncology Therap... "Business Wire" - 1/6/2016 8:00:00 AM
Rosetta Genomics & Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA Profiling of Circulating Tumor... "Business Wire" - 12/14/2015 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/3/2015 12:00:46 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/3/2015 7:01:24 AM
Rosetta Genomics Reports Third Quarter 2015 Financial Results "Business Wire" - 12/1/2015 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/1/2015 7:51:56 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/23/2015 5:09:35 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/23/2015 11:45:04 AM
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal™ (Thyroid microRNA Classifier) "Business Wire" - 11/12/2015 8:58:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 11/12/2015 6:01:49 AM
Rosetta Genomics Appoints Dr. Maria Fe Paz as Interim Chief Medical Officer "Business Wire" - 11/4/2015 8:30:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/3/2015 8:40:00 AM
Securities Registration (foreign Private Issuer) (f-3) "Edgar (US Regulatory)" - 10/30/2015 4:07:15 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/27/2015 5:02:38 PM
Rosetta Genomics Reports Financial Results for the First Half of 2015 "Business Wire" - 10/26/2015 5:19:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/26/2015 4:05:07 PM
Positive Performance Data from Validation Study of Rosetta Genomics’ microRNA-based Diagnostic Assay for Thyroid Nodule Cla... "Business Wire" - 10/21/2015 9:20:00 AM
Rosetta Genomics to Host Business Update and Six Month Financials Conference Call on October 27, 2015 "Business Wire" - 10/20/2015 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist